PRNAF OTC
Alterity Therapeutics Limited
1W: +0.0%
1M: +0.0%
3M: +627.3%
YTD: +6249.2%
1Y: +13233.3%
3Y: +7447.2%
5Y: +1631.6%
$0.40
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$46M
-0.2% ▼
5Y CAGR: +6.5%
Total Liabilities
$3M
-9.2% ▼
5Y CAGR: +1.1%
Shareholders Equity
$43M
+0.6% ▲
5Y CAGR: +7.0%
Cash & Investments
$37M
-8.3% ▼
5Y CAGR: +5.8%
Total Debt
$193K
+24.3% ▲
5Y CAGR: +24.1%
Net Debt
-$37M
-12.3% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $35M | $16M | $13M | $33M | $37M |
| Short-Term Investments | $0 | $0 | $0 | $8M | $0 |
| Cash & ST Investments | $35M | $16M | $13M | $41M | $37M |
| Net Receivables | $5M | $9M | $4M | $4M | $8M |
| Inventory | $2M | $3M | $0 | $0 | $0 |
| Other Current Assets | -$2M | -$3M | $63K | $42K | $811K |
| Total Current Assets | $41M | $27M | $19M | $46M | $46M |
| Property, Plant & Equip. | $219K | $269K | $187K | $155K | $190K |
| Goodwill & Intangibles | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Assets | $0 | $0 | $0 | $0 | $0 |
| Total Non-Current Assets | $219K | $269K | $187K | $155K | $190K |
| Total Assets | $41M | $27M | $19M | $46M | $46M |
| — Liabilities — | |||||
| Accounts Payable | $3M | $2M | $581K | $538K | $1M |
| Short-Term Debt | $0 | $0 | $0 | $0 | $55K |
| Deferred Revenue | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $85K | $62K | $100K | $876K | $2M |
| Total Current Liabilities | $6M | $4M | $5M | $4M | $3M |
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Liab. | $14K | $20K | $0 | $0 | $0 |
| Total Non-Current Liabilities | $74K | $123K | $52K | $89K | $138K |
| Total Liabilities | $6M | $5M | $5M | $4M | $3M |
| — Equity — | |||||
| Common Stock | $214M | $214M | $223M | $263M | $0 |
| Retained Earnings | -$182M | -$195M | -$214M | -$226M | -$245M |
| Accumulated OCI | $4M | $4M | $5M | $0 | $0 |
| Total Stockholders Equity | $35M | $23M | $14M | $42M | $43M |
| Total Liabilities & Equity | $41M | $27M | $19M | $46M | $46M |
| — Key Metrics — | |||||
| Total Debt | $117K | $210K | $159K | $155K | $193K |
| Net Debt | -$35M | -$16M | -$12M | -$33M | -$37M |
| Total Investments | $0 | $0 | $0 | $8M | $0 |